• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化门静脉高压症伴脾功能亢进患者的外周血细胞变化。

Peripheral blood cell variations in cirrhotic portal hypertension patients with hypersplenism.

机构信息

Department of Surgery, People's Hospital of Hainan Province, Haikou, China.

出版信息

Asian Pac J Trop Med. 2013 Aug;6(8):663-6. doi: 10.1016/S1995-7645(13)60115-7.

DOI:10.1016/S1995-7645(13)60115-7
PMID:23790341
Abstract

OBJECTIVE

To explore peripheral blood cell variations in hepatic cirrhosis portal hypertension patients with hypersplenism.

METHODS

Clinical data of 322 hypersplenism patients with decreased peripheral blood cells, admitted with cirrhotic portal hypertension, was retrospectively studied over the last 17 years.

RESULTS

In 64% (206/322) of patients, more than 2 kinds of blood cell were decreased, including 89 cases of pancytopenia (43.2%), 52 cases of WBC + PLT decrease (25.2%), 29 cases of RBC + PLT decrease (14.1%), and 36 cases of WBC + RBC decrease (17.5%); in 36% (116/322) of patients, single type blood cell decrease occurred, including 31 cases of PLT decrease (26.7%), 29 cases of WBC decrease (25%) and 56 cases of RBC decrease (48.3%). Of 227 routine bone marrow examinations, bone marrow hyperplasia was observed in 118 cases (52.0%), the remainder showed no hyperplasia. For the distinct scope and extent of peripheralblood cell decreases, preoperative blood component transfusions were carried out, then treated by surgery, after whole group splenectomy, the peripheral blood cell count was significantly higher (P<0.05).

CONCLUSIONS

Of portal hypertensive patients with splenomegaly and hypersplenism, 64% have simultaneous decrease in various blood cells, 36% have decrease in single type blood cells, 52% of patients have bone marrow hyperplasia. A splenectomy can significantly increase the reduction of peripheral blood cells.

摘要

目的

探讨肝硬化门静脉高压症合并脾功能亢进患者外周血细胞变化。

方法

回顾性分析 17 年来收治的 322 例外周血细胞减少的肝硬化门静脉高压症合并脾功能亢进患者的临床资料。

结果

64%(206/322)的患者有两种以上血细胞减少,包括全血细胞减少 89 例(43.2%)、白细胞+血小板减少 52 例(25.2%)、红细胞+血小板减少 29 例(14.1%)、白细胞+红细胞减少 36 例(17.5%);36%(116/322)的患者发生单一类型血细胞减少,包括血小板减少 31 例(26.7%)、白细胞减少 29 例(25%)、红细胞减少 56 例(48.3%)。227 例行常规骨髓检查,骨髓增生 118 例(52.0%),无增生 109 例。根据外周血细胞减少的明显程度和范围,术前进行血液成分输注,然后手术治疗,全组脾切除后,外周血白细胞计数明显升高(P<0.05)。

结论

肝硬化门静脉高压症伴脾肿大、脾功能亢进患者中,64%同时存在多种血细胞减少,36%存在单一类型血细胞减少,52%患者骨髓增生。脾切除术可显著增加外周血血细胞减少。

相似文献

1
Peripheral blood cell variations in cirrhotic portal hypertension patients with hypersplenism.肝硬化门静脉高压症伴脾功能亢进患者的外周血细胞变化。
Asian Pac J Trop Med. 2013 Aug;6(8):663-6. doi: 10.1016/S1995-7645(13)60115-7.
2
Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly.肝硬化和门静脉高压性脾肿大导致外周血细胞减少的原因。
Exp Biol Med (Maywood). 2017 Apr;242(7):744-749. doi: 10.1177/1535370217693113. Epub 2017 Jan 1.
3
Effect of surgery treatment on hypersplenism caused by cirrhotic portal hypertension.手术治疗对肝硬化门静脉高压症所致脾功能亢进的影响。
Minerva Chir. 2013 Aug;68(4):409-13.
4
Clinical study on the relationship between hematocytopenia and splenomegaly caused by cirrhotic portal hypertension.肝硬化门静脉高压所致血细胞减少与脾肿大关系的临床研究
Cell Biochem Biophys. 2014 Sep;70(1):355-60. doi: 10.1007/s12013-014-9920-9.
5
Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: a pilot study.肝硬化患者脾功能亢进的射频消融治疗:一项初步研究。
J Gastrointest Surg. 2005 May-Jun;9(5):648-57. doi: 10.1016/j.gassur.2004.11.006.
6
Technical standardization of laparoscopic splenectomy harmonized with hand-assisted laparoscopic surgery for patients with liver cirrhosis and hypersplenism.腹腔镜脾切除术与手辅助腹腔镜手术治疗肝硬化脾功能亢进患者的技术标准化
J Hepatobiliary Pancreat Surg. 2009;16(6):749-57. doi: 10.1007/s00534-009-0149-8. Epub 2009 Jul 22.
7
Laparoscopic splenectomy in portal hypertension: a single-surgeon 13-year experience.腹腔镜脾切除术治疗门静脉高压症:单外科医生 13 年经验。
Surg Endosc. 2010 May;24(5):1164-9. doi: 10.1007/s00464-009-0744-4. Epub 2009 Dec 22.
8
[Role of splenectomy in the therapy of hypersplenism associated with intrahepatic portal hypertension].脾切除术在肝内门静脉高压症相关脾功能亢进治疗中的作用
Minerva Chir. 1984 Jun 30;39(12):953-6.
9
Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension.肝硬化门静脉高压症相关脾功能亢进患者全脾切除对周围淋巴细胞及其亚群的影响。
Sci Rep. 2021 Oct 28;11(1):21246. doi: 10.1038/s41598-021-00692-x.
10
[Spleno-renal distal and proximal shunts for hypersplenism due to hepatic cirrhosis].[脾肾远端和近端分流术治疗肝硬化所致脾功能亢进]
Chirurgia (Bucur). 2007 Nov-Dec;102(6):665-8.

引用本文的文献

1
Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter randomized controlled trial.部分脾栓塞联合内镜治疗及血管收缩药物可减少肝硬化急性静脉曲张出血合并脾功能亢进患者的再出血:一项多中心随机对照试验
J Gastroenterol. 2023 Nov;58(11):1144-1153. doi: 10.1007/s00535-023-02027-1. Epub 2023 Jul 24.
2
Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT.用于评估 ALT 正常的初治 HBeAg 阳性慢性乙型肝炎病毒感染患者明显肝脏炎症的列线图。
Virulence. 2023 Dec;14(1):2158710. doi: 10.1080/21505594.2022.2158710.
3
Investigation into imbalance of Th1/Th2 cells in cirrhotic, hypersplenic rats.
探讨肝硬化、脾亢大鼠 Th1/Th2 细胞失衡。
J Int Med Res. 2020 Mar;48(3):300060519889441. doi: 10.1177/0300060519889441. Epub 2019 Dec 18.
4
Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease.晚期慢性肝病患者贫血的患病率及相关危险因素。
Liver Int. 2020 Jan;40(1):194-204. doi: 10.1111/liv.14229. Epub 2019 Sep 13.
5
The Effect of Splenectomy on the Reversal of Cirrhosis: a Prospective Study.脾切除术对肝硬化逆转的影响:一项前瞻性研究。
Gastroenterol Res Pract. 2019 Apr 8;2019:5459427. doi: 10.1155/2019/5459427. eCollection 2019.
6
Host Immunological Effects of Partial Splenic Embolization in Patients with Liver Cirrhosis.肝硬化患者部分脾脏栓塞的宿主免疫效应。
J Immunol Res. 2018 Jul 15;2018:1746391. doi: 10.1155/2018/1746391. eCollection 2018.
7
Combination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients.PCT、sNFI 和 dCHC 联合用于诊断肝硬化患者腹水感染。
BMC Infect Dis. 2018 Aug 10;18(1):389. doi: 10.1186/s12879-018-3308-1.
8
Distribution characteristics of cells in splenomegaly due to hepatitis B-related cirrhotic portal hypertension and their clinical importance.乙型肝炎相关性肝硬化门静脉高压所致脾肿大的细胞分布特征及其临床意义。
J Int Med Res. 2018 Jul;46(7):2633-2640. doi: 10.1177/0300060518767550. Epub 2018 May 20.
9
Spleen Regulates Hematopoietic Stem/Progenitor Cell Functions Through Regulation of EGF in Cirrhotic Hypersplenism.脾脏通过调节肝硬化性脾功能亢进症中的 EGF 来调节造血干/祖细胞功能。
Dig Dis Sci. 2018 Jul;63(7):1860-1867. doi: 10.1007/s10620-018-5091-7. Epub 2018 May 3.
10
Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly.肝硬化和门静脉高压性脾肿大导致外周血细胞减少的原因。
Exp Biol Med (Maywood). 2017 Apr;242(7):744-749. doi: 10.1177/1535370217693113. Epub 2017 Jan 1.